REGD. NO. D. L.-33004/99 The Gazette of India
EXTRAORDINARY
PART II—Section 3—Sub-section (i)
PUBLISHED BY AUTHORITY
No. 106] NEW DELHI, MONDAY, MARCH 12, 2001/PHALGUNA21.1922 2 THE GAZETTE OF INDIA; EXTRAORDINARY [PART II—SEC.3(i)] MINISTRY OFHEALTH AND FA1VDLY WELFARE (Department of Health)
NOTIFICATION
NewDelhi, the 12thMarch, 2001
G.S.R. 170 (E).—Whereas the Central Government is satisfied that the use of the drugs specified below do not have the therapeutic value claimed or purported to be claimed for them or the said drugs contain ingredients and in such quantity for which there is no therapeutic justification and that in the public interest it is necessary and expedient to prohibit the manufacture, sale and distribution of the said drugs;
Now, therefore, in exercise of the powers conferred by section 26-A of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government hereby prohibits the manufacture, sale and distribution of the said drugs for human use with effect from 1st January, 2002.
1. Fixed dose combination of Nitrofurantoin and Trimethoprim.
2 Fixed dose combination of Phenobarbitone with any anti-asthamatic drugs.
3. Fixed dose combination of Phenobarbitone with Hyoscin and/or Hyoscyanune.
4. Fixed dose combination of Phenobarbitone with Ergotamine and/or Belladona.
5. Fixed dose combination of Haloperidol with any anti-cholinergic agent including Propentheline Bromide.
6. Fixed dose combination of Nalidixic acid with any anti-amoebics including Metronidazole.
7. Fixed dose combination of Lopcramide Hydrochloride with Furazolidone.
8. Fixed dose combina tion of Cyproheptadine with Lysine, or Peptone.
[F. No. X-11014/10/2000-DMS &PFAJ
DEEPAK GUPTA, Jt. Secy.
Foot Note:—Principal Notification was published vide G. S.R. 578 (E) dated 23-7-1983 and last amended vide G. S.R. No 40 (E) dated,